Tests to detect the presence and activity of hepatitis B virus (HBV) are the cornerstones of
diagnosis and management. Assays that detect or measure serum levels of HB surface …

Even though an approved vaccine for hepatitis B virus (HBV) is available and widely used,
over 257 million individuals worldwide are living with chronic hepatitis B (CHB) who require …

Fatal hepatitis B virus (HBV) reactivation in lymphoma patients with “resolved” HBV infection
(hepatitis B surface antigen [HBsAg] negative and hepatitis B core antibody [anti‐HBc] …

Objective The investigation regarding the clinical significance of quantitative hepatitis B core
antibody (anti-HBc) during chronic hepatitis B (CHB) treatment is limited. The aim of this …

We previously demonstrated that pretreatment quantitative anti–hepatitis B core protein
(qAnti-HBc) levels can predict the treatment response for both interferon and nucleoside …

Hepatitis B virus (HBV) infection is an important public health problem in Canada. In keeping
with evolving evidence and understanding of HBV pathogenesis, the Canadian Association …

Background & Aims Levels of antibodies against the hepatitis B virus (HBV) core protein
(anti-HBc) have been associated with response to nucleos (t) ide analogue and (peg) …

Background & Aims Absence or low anti-HBV surface antibody (anti-HBs) is associated with
an increased risk of HBV reactivation in patients with lymphoma and resolved HBV infection …

The present-day management of hepatitis B virus (HBV) infection relies on constant and
appropriate monitoring of viral activity, disease progression and treatment response …

With recent advances in molecular and genomic investigations, the impact of hepatitis B viral
and host factors on the progression of chronic HBV infection has been explored. For viral …